Es gab 50 kürzliche Insider-Transaktionen für Immuneering Corporation (IMRX), darunter 49 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $12.4M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Neufeld Leah R, Matushansky Igor, Bookman Michael. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — IMRX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-13 |
Neufeld Leah R |
Chief People Officer |
RSU-Zuteilung |
3,628 |
$4.29 |
$15.57K |
29,598 |
| 2026-02-03 |
Matushansky Igor |
Chief Medical Officer |
RSU-Zuteilung |
140,000 |
$4.91 |
$687.4K |
140,000 |
| 2026-02-03 |
Bookman Michael |
Chief Legal Officer, Secretary |
RSU-Zuteilung |
176,000 |
$4.91 |
$864.16K |
176,000 |
| 2026-02-03 |
Zeskind Benjamin J. |
President and CEO |
RSU-Zuteilung |
688,000 |
$4.91 |
$3.38M |
688,000 |
| 2026-02-03 |
Hall Brett Matthew |
Chief Scientific Officer |
RSU-Zuteilung |
344,000 |
$4.91 |
$1.69M |
344,000 |
| 2026-02-03 |
Morales Mallory |
SVP Finance, CAO |
RSU-Zuteilung |
140,000 |
$4.91 |
$687.4K |
140,000 |
| 2026-02-03 |
Neufeld Leah R |
Chief People Officer |
RSU-Zuteilung |
140,000 |
$4.91 |
$687.4K |
140,000 |
| 2026-02-03 |
Brakewood Harold Eugene |
Chief Business Officer |
RSU-Zuteilung |
140,000 |
$4.91 |
$687.4K |
140,000 |
| 2026-01-16 |
Brakewood Harold Eugene |
Chief Business Officer |
Informierter Kauf |
5,250 |
$4.76 |
$24.99K |
11,050 |
| 2026-01-15 |
Hall Brett Matthew |
Chief Scientific Officer |
Informierter Kauf |
2,298 |
$4.57 |
$10.5K |
376,496 |
| 2026-01-15 |
Schall Thomas J. |
Director |
Informierter Kauf |
21,645 |
$4.67 |
$101.04K |
74,530 |
| 2026-01-13 |
Neufeld Leah R |
Chief People Officer |
Informierter Kauf |
2,626 |
$4.15 |
$10.91K |
25,970 |
| 2026-01-12 |
Feinberg Peter |
Director |
Informierter Kauf |
20,000 |
$4.35 |
$86.9K |
135,441 |
| 2026-01-01 |
Keating Laurie |
Director |
RSU-Zuteilung |
7,888 |
$6.58 |
$51.9K |
7,888 |
| 2026-01-01 |
Feinberg Peter |
Director |
RSU-Zuteilung |
7,888 |
$6.58 |
$51.9K |
7,888 |
| 2025-10-03 |
Feinberg Peter |
Director |
Informierter Kauf |
7,500 |
$6.67 |
$50.03K |
156,766 |
| 2025-10-01 |
Bookman Michael |
Chief Legal Officer, Secretary |
Informierter Kauf |
1,020 |
$6.83 |
$6.97K |
4,870 |
| 2025-10-01 |
Morales Mallory |
Chief Accounting Officer |
Informierter Kauf |
300 |
$6.39 |
$1.92K |
27,533 |
| 2025-10-01 |
Neufeld Leah R |
Chief People Officer |
Informierter Kauf |
800 |
$6.38 |
$5.1K |
23,344 |
| 2025-09-30 |
Feinberg Peter |
Director |
Informierter Kauf |
7,500 |
$7.03 |
$52.73K |
149,266 |
| 2025-09-29 |
Feinberg Peter |
Director |
Informierter Kauf |
5,000 |
$7.18 |
$35.9K |
141,766 |
| 2025-09-15 |
Hall Brett Matthew |
Chief Scientific Officer |
RSU-Zuteilung |
14,880 |
$1.43 |
$21.25K |
374,198 |
| 2025-09-15 |
Morales Mallory |
Chief Accounting Officer |
RSU-Zuteilung |
14,497 |
$1.43 |
$20.7K |
27,233 |
| 2025-09-15 |
Neufeld Leah R |
Chief People Officer |
RSU-Zuteilung |
11,815 |
$1.43 |
$16.87K |
22,544 |
| 2025-07-02 |
Zeskind Benjamin J. |
10 Percent Owner, Officer: President and CEO |
Informierter Kauf |
7,015 |
$3.53 |
$24.79K |
2,312,852 |
| 2025-07-02 |
Hausman Diana |
Director |
Informierter Kauf |
2,500 |
$3.60 |
$8.99K |
2,500 |
| 2025-07-02 |
Neufeld Leah R |
Chief People Officer |
Informierter Kauf |
700 |
$3.57 |
$2.5K |
10,729 |
| 2025-07-01 |
Zeskind Benjamin J. |
10 Percent Owner, Officer: President and CEO |
Informierter Kauf |
2,985 |
$3.38 |
$10.09K |
2,305,837 |
| 2025-06-27 |
Schall Thomas J. |
Director |
Informierter Kauf |
9,500 |
$3.66 |
$34.79K |
52,885 |
| 2025-06-23 |
Hall Brett Matthew |
Chief Scientific Officer |
Informierter Kauf |
6,007 |
$2.43 |
$14.6K |
359,318 |
| 2025-06-20 |
Hall Brett Matthew |
Chief Scientific Officer |
Informierter Kauf |
7,415 |
$2.70 |
$20.02K |
353,311 |
| 2025-06-20 |
Brakewood Harold Eugene |
Chief Business Officer |
Informierter Kauf |
1,900 |
$2.53 |
$4.8K |
5,800 |
| 2025-06-18 |
Zeskind Benjamin J. |
10 Percent Owner, Officer: President and CEO |
Informierter Kauf |
21,000 |
$2.39 |
$50.14K |
2,302,852 |
| 2025-06-18 |
Feinberg Peter |
Director |
Informierter Kauf |
25,000 |
$2.53 |
$63.19K |
136,766 |
| 2025-06-17 |
Schall Thomas J. |
Director |
Informierter Kauf |
40,485 |
$2.21 |
$89.28K |
43,385 |
| 2025-06-13 |
Carpenter Robert J |
Director |
RSU-Zuteilung |
33,350 |
$1.90 |
$63.37K |
33,350 |
| 2025-06-13 |
Berman Ann E |
Director |
RSU-Zuteilung |
33,350 |
$1.90 |
$63.37K |
33,350 |
| 2025-06-13 |
Schall Thomas J. |
Director |
RSU-Zuteilung |
33,350 |
$1.90 |
$63.37K |
33,350 |
| 2025-06-13 |
Hausman Diana |
Director |
RSU-Zuteilung |
33,350 |
$1.90 |
$63.37K |
33,350 |
| 2025-06-13 |
Keating Laurie |
Director |
RSU-Zuteilung |
33,350 |
$1.90 |
$63.37K |
33,350 |
| 2025-06-13 |
Feinberg Peter |
Director |
RSU-Zuteilung |
33,350 |
$1.90 |
$63.37K |
33,350 |
| 2025-03-21 |
Matushansky Igor |
Chief Medical Officer |
RSU-Zuteilung |
118,000 |
$1.80 |
$212.4K |
118,000 |
| 2025-03-17 |
Matushansky Igor |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-02-05 |
Bookman Michael |
Chief Legal Officer, Secretary |
RSU-Zuteilung |
110,000 |
$1.91 |
$210.1K |
110,000 |
| 2025-02-05 |
Zeskind Benjamin J. |
10 Percent Owner, Officer: President and CEO |
RSU-Zuteilung |
480,000 |
$1.91 |
$916.8K |
480,000 |
| 2025-02-05 |
Hall Brett Matthew |
Chief Scientific Officer |
RSU-Zuteilung |
240,000 |
$1.91 |
$458.4K |
240,000 |
| 2025-02-05 |
Morales Mallory |
Chief Accounting Officer |
RSU-Zuteilung |
110,000 |
$1.91 |
$210.1K |
110,000 |
| 2025-02-05 |
Neufeld Leah R |
Chief People Officer |
RSU-Zuteilung |
110,000 |
$1.91 |
$210.1K |
110,000 |
| 2025-02-05 |
Brakewood Harold Eugene |
Chief Business Officer |
RSU-Zuteilung |
100,000 |
$1.91 |
$191K |
100,000 |
| 2025-01-01 |
Berman Ann E |
Director |
RSU-Zuteilung |
17,614 |
$2.20 |
$38.75K |
17,614 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
